Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Each fits different research questions
Escartin C, Galea E, Lakatos A, O'Callaghan JP, Petzold GC, Serrano-Pozo A, et al
Another is comparing unlike options or skipping the linked supporting information that adds context and reduces guesswork
US$ 25.90
US$ 23.81
US$ 22.23
US$ 20.72
US$ 24.48
US$ 22.44
